Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NPC-12Y oily gel vs placebo in tuberous sclerosis complex skin lesions
jRCT2041220051Completed
- Sponsor
- Nobelpharma Co., Ltd.
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in tuberous sclerosis complex (TSC), facial angiofibroma and periungual fibroma comparing NPC-12Y oily gel with Placebo gel (2 arms). Started Jul 2022; status: completed.
02
Drugs
sirolimus
03
Conditions
tuberous sclerosis complex (TSC)facial angiofibromaperiungual fibroma
Beyond the preview
Go deeper on jRCT2041220051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2041220051.